©Getty Images/FG Trade Latin
- The drug overdose and addiction crisis collided with the COVID-19 pandemic, with the potential to worsen the negative impacts of each for individuals. People who use drugs are more vulnerable to acquiring the virus that can cause COVID-19 and more likely to have worse health outcomes.
- However, the pandemic also led to opportunities for health care providers, substance use disorder recovery support systems, and other services to reach more people. For example, the U.S. government allowed flexibility for remote prescribing of buprenorphine and take-home dosing of methadone, medications used to treat opioid use disorder.
- NIDA conducts and supports research on the impacts of the COVID-19 pandemic on substance use and related health outcomes, and how the pandemic impacted adolescent health and brain development, including mental health and substance use. The institute is also researching sustainable, evidence-based strategies to overcome structural barriers to care.
Latest from NIDA
Overdose deaths involving buprenorphine did not proportionally increase with new flexibilities in prescribing
Social connectedness, sleep, and physical activity associated with better mental health among youth during the COVID-19 pandemic
Media Briefing: NIH Leaders to speak at the Society for Neuroscience Annual Meeting about NIH COVID-19 research and the neurological implications of COVID-19
Find More Resources on COVID-19 and Substance Use Disorders
- Find a COVID-19 vaccine near you at Vaccines.gov.
- Read more information on COVID-19 risk and severity among people who use substances from the Centers for Disease Control and Prevention (CDC).
- See more COVID-19 research at the National Institutes of Health.
- Researchers: Find coronavirus COVID-19 information for NIH applicants and recipients of NIH funding.